IMMUNOLOGICAL CHARACTERIZATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE PROTEIN BY THE USE OF MONOCLONAL-ANTIBODIES

被引:18
作者
ORVELL, C
UNGE, T
BHIKHABHAI, R
BACKBRO, K
RUDEN, U
STRANDBERG, B
WAHREN, B
FENYO, EM
机构
[1] UPPSALA UNIV,UPPSALA BIOMED CTR,DEPT MOLEC BIOL,S-75124 UPPSALA,SWEDEN
[2] KAROLINSKA INST,DEPT VIROL,S-10401 STOCKHOLM 60,SWEDEN
关键词
D O I
10.1099/0022-1317-72-8-1913
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Eighteen monoclonal antibodies (MAbs) directed against the purified human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) protein were produced. The antibodies were characterized by competitive ELISAs and Western blot experiments, and with nested, nine amino acid long peptides representing the whole 560 amino acid RT protein. By ELISA, the MAbs react with a minimum of seven epitopes of the protein. Four of the epitopes were located on the N-terminal 51K subunit and the remaining three epitopes were located at the C-terminal end of the protein. Using synthetic peptides, two epitopes at the N-terminal part were located at amino acids 294 to 302 and 350 to 354, respectively, from the N-terminal start of the protein. One epitope was located at amino acids 442 to 450, just after the cleavage site between the N-terminal and C-terminal subunit at position 440. Antibodies located at amino acids 294 to 302 could inhibit the RT enzymic activity of the protein. Two other MAbs, directed at the N-terminal and C-terminal parts of the protein, could also inhibit RT activity.
引用
收藏
页码:1913 / 1918
页数:6
相关论文
共 30 条
[11]   AIDS VIRUS REVERSE-TRANSCRIPTASE DEFINED BY HIGH-LEVEL EXPRESSION IN ESCHERICHIA-COLI [J].
LARDER, B ;
PURIFOY, D ;
POWELL, K ;
DARBY, G .
EMBO JOURNAL, 1987, 6 (10) :3133-3137
[12]   INFECTIOUS POTENTIAL OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 REVERSE-TRANSCRIPTASE MUTANTS WITH ALTERED INHIBITOR SENSITIVITY [J].
LARDER, BA ;
KEMP, SD ;
PURIFOY, DJM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) :4803-4807
[13]   SITE-SPECIFIC MUTAGENESIS OF AIDS VIRUS REVERSE-TRANSCRIPTASE [J].
LARDER, BA ;
PURIFOY, DJM ;
POWELL, KL ;
DARBY, G .
NATURE, 1987, 327 (6124) :716-717
[14]   A SINGLE 66-KILODALTON POLYPEPTIDE PROCESSED FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 POL POLYPROTEIN IN ESCHERICHIA-COLI DISPLAYS REVERSE-TRANSCRIPTASE ACTIVITY [J].
LEGRICE, SFJ ;
ZEHNLE, R ;
MOUS, J .
JOURNAL OF VIROLOGY, 1988, 62 (07) :2525-2529
[15]   STRUCTURAL CHARACTERIZATION OF REVERSE-TRANSCRIPTASE AND ENDONUCLEASE POLYPEPTIDES OF THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME RETROVIRUS [J].
LIGHTFOOTE, MM ;
COLIGAN, JE ;
FOLKS, TM ;
FAUCI, AS ;
MARTIN, MA ;
VENKATESAN, S .
JOURNAL OF VIROLOGY, 1986, 60 (02) :771-775
[16]   SITE-DIRECTED MUTAGENESIS OF THE CONSERVED ASP-443 AND ASP-498 CARBOXY-TERMINAL RESIDUES OF HIV-1 REVERSE-TRANSCRIPTASE [J].
MIZRAHI, V ;
USDIN, MT ;
HARINGTON, A ;
DUDDING, LR .
NUCLEIC ACIDS RESEARCH, 1990, 18 (18) :5359-5363
[17]   PROCESSING PROTEASE AND REVERSE-TRANSCRIPTASE FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE-I POLYPROTEIN IN ESCHERICHIA-COLI [J].
MOUS, J ;
HEIMER, EP ;
LEGRICE, SFJ .
JOURNAL OF VIROLOGY, 1988, 62 (04) :1433-1436
[18]  
Nakane M. B., 1978, IMMUNOFLUORESCENCE R, P215
[19]   HIV REVERSE-TRANSCRIPTASE INHIBITING ANTIBODIES DETECTED BY A NEW TECHNIQUE - RELATION TO P24 AND GP41 ANTIBODIES, HIV ANTIGENEMIA AND CLINICAL-VARIABLES [J].
NEUMULLER, M ;
KARLSSON, A ;
LENNERSTRAND, J ;
KALLANDER, CFR ;
HOLMBERG, V ;
LANGSTROMPERSSON, U ;
THORSTENSSON, R ;
SANDSTROM, E ;
GRONOWITZ, JS .
JOURNAL OF MEDICAL VIROLOGY, 1991, 34 (01) :55-63
[20]  
NEUMULLER M, 1990, BIOTECHNOL APPL BIOC, V12, P34